Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 82

1.

Case studies in swelling polymeric gastric retentive tablets.

Berner B, Cowles VE.

Expert Opin Drug Deliv. 2006 Jul;3(4):541-8.

PMID:
16822228
2.

Two- and three-layer tablet drug delivery systems for oral sustained release of soluble and poorly soluble drugs.

Efentakis M, Naseef H, Vlachou M.

Drug Dev Ind Pharm. 2010 Aug;36(8):903-16. doi: 10.3109/03639040903585119.

PMID:
20196641
3.

Pharmacokinetics of metformin gastric-retentive tablets in healthy volunteers.

Gusler G, Gorsline J, Levy G, Zhang SZ, Weston IE, Naret D, Berner B.

J Clin Pharmacol. 2001 Jun;41(6):655-61.

PMID:
11402634
4.

Metformin extended release: metformin gastric retention, metformin GR, metformin XR.

[No authors listed]

Drugs R D. 2005;6(5):316-9. Review.

PMID:
16128603
5.

Sustained-release matrix tablets of metformin hydrochloride in combination with triacetyl-beta-cyclodextrin.

Corti G, Cirri M, Maestrelli F, Mennini N, Mura P.

Eur J Pharm Biopharm. 2008 Feb;68(2):303-9. Epub 2007 Jun 12.

PMID:
17616379
6.

Gastroretentive drug delivery system of metoclopramide hydrochloride: formulation and in vitro evaluation.

Singh S, Singh J, Muthu MS, Balasubramaniam J, Mishra B.

Curr Drug Deliv. 2007 Oct;4(4):269-75.

PMID:
17979646
7.

In vitro evaluation of a system for pH-controlled peroral delivery of metformin.

Di Colo G, Falchi S, Zambito Y.

J Control Release. 2002 Apr 23;80(1-3):119-28.

PMID:
11943392
8.

In vitro and in vivo sustained-release characteristics of theophylline matrix tablets and novel cluster tablets.

Hayashi T, Kanbe H, Okada M, Kawase I, Ikeda Y, Onuki Y, Kaneko T, Sonobe T.

Int J Pharm. 2007 Aug 16;341(1-2):105-13. Epub 2007 Apr 5.

PMID:
17512147
9.

Design and in vitro testing of a floatable gastroretentive tablet of metformin hydrochloride.

Basak SC, Rahman J, Ramalingam M.

Pharmazie. 2007 Feb;62(2):145-8.

PMID:
17341036
10.

A site-specific controlled-release system for metformin.

Di Colo G, Zambito Y, Baggiani A, Carelli V, Serafini MF.

J Pharm Pharmacol. 2005 May;57(5):565-71.

PMID:
15901345
11.

Assessing gastrointestinal motility and disintegration profiles of magnetic tablets by a novel magnetic imaging device and gamma scintigraphy.

Goodman K, Hodges LA, Band J, Stevens HN, Weitschies W, Wilson CG.

Eur J Pharm Biopharm. 2010 Jan;74(1):84-92. doi: 10.1016/j.ejpb.2009.01.004. Epub 2009 Jan 20.

PMID:
19602377
12.
13.

Clinical development of metformin extended-release tablets for type 2 diabetes: an overview.

Schwartz SL, Gordi T, Hou E, Cramer M, Heritier M, Cowles VE.

Expert Opin Drug Metab Toxicol. 2008 Sep;4(9):1235-43. doi: 10.1517/17425255.4.9.1235.

PMID:
18721117
14.

Extrudable core system: development of a single-layer osmotic controlled-release tablet.

Waterman KC, MacDonald BC, Roy MC.

J Control Release. 2009 Mar 19;134(3):201-6. doi: 10.1016/j.jconrel.2008.11.017. Epub 2008 Dec 3.

PMID:
19100796
15.

Preparation, in vitro, preclinical and clinical evaluations of once daily sustained release tablets of aceclofenac.

Mutalik S, Naha A, Usha AN, Ranjith AK, Musmade P, Manoj K, Anju P, Prasanna S.

Arch Pharm Res. 2007 Feb;30(2):222-34.

PMID:
17366745
16.

Thiomers for oral delivery of hydrophilic macromolecular drugs.

Bernkop-Schnürch A, Hoffer MH, Kafedjiiski K.

Expert Opin Drug Deliv. 2004 Nov;1(1):87-98. Review.

PMID:
16296722
17.

Design and in vitro/in vivo evaluation of novel nicorandil extended release matrix tablets based on hydrophilic interpolymer complexes and a hydrophobic waxy polymer.

Abdelbary GA, Tadros MI.

Eur J Pharm Biopharm. 2008 Aug;69(3):1019-28. doi: 10.1016/j.ejpb.2008.01.011. Epub 2008 Jan 19.

PMID:
18295465
18.

Membrane formation and drug loading effects in high amylose starch tablets studied by NMR imaging.

Thérien-Aubin H, Zhu XX, Ravenelle F, Marchessault RH.

Biomacromolecules. 2008 Apr;9(4):1248-54. doi: 10.1021/bm701256z. Epub 2008 Mar 22.

PMID:
18357992
19.

Magnetic marker monitoring: high resolution real-time tracking of oral solid dosage forms in the gastrointestinal tract.

Weitschies W, Blume H, Mönnikes H.

Eur J Pharm Biopharm. 2010 Jan;74(1):93-101. doi: 10.1016/j.ejpb.2009.07.007. Epub 2009 Jul 18.

PMID:
19619649
20.

A ciprofloxacin extended release tablet based on swellable drug polyelectrolyte matrices.

Bermúdez JM, Jimenez-Kairuz AF, Olivera ME, Allemandi DA, Manzo RH.

AAPS PharmSciTech. 2008;9(3):924-30. doi: 10.1208/s12249-008-9098-9. Epub 2008 Aug 7.

Supplemental Content

Support Center